
Pfizer Inc. (NYSE: PFE) helped boost the Dow Jones Industrial Average (DJIA) the day after delivering a double beat in its fourth-quarter earnings report.
Revenue of $17.56 billion topped analysts' estimates of $16.93. On the bottom line, Pfizer delivered adjusted earnings per share (EPS) of 69 cents, beating estimates of 57 cents. Highlighting the report was Pfizer’s announcement of positive topline results from the Phase 2b study for its lead GLP-1 drug candidate.
PFE stock closed up 4% on Feb. 4 as analysts and investors had an opportunity to digest the report.